about
Protein carbamylation and cardiovascular diseaseModified Lipids and Lipoproteins in Chronic Kidney Disease: A New Class of Uremic ToxinsResidual Cardiovascular Risk in Chronic Kidney Disease: Role of High-density LipoproteinDifferential scaling of glomerular filtration rate and ingested metabolic burden: implications for gender differences in chronic kidney disease outcomesProtein carbamylation in kidney disease: pathogenesis and clinical implicationsDietary protein metabolism by gut microbiota and its consequences for chronic kidney disease patients.Chronic increase of urea leads to carbamylated proteins accumulation in tissues in a mouse model of CKDEndogenous carbamylation of renal medullary proteins.Alterations of intestinal barrier and microbiota in chronic kidney disease.Protein carbamylation is associated with heart failure and mortality in diabetic patients with end-stage renal disease.The Effects of Parenteral Amino Acid Therapy on Protein Carbamylation in Maintenance Hemodialysis Patients.Carbamylated Low-Density Lipoprotein (cLDL)-Mediated Induction of Autophagy and Its Role in Endothelial Cell Injury.Protein carbamylation is a hallmark of agingUrea and protein carbamylation in ESRD: surrogate markers or partners in crime?Urea impairs β cell glycolysis and insulin secretion in chronic kidney disease.Carbamylation of serum albumin and erythropoietin resistance in end stage kidney disease.Emerging role of post-translational modifications in chronic kidney disease and cardiovascular disease.Intercellular communication lessons in heart failure.Reduction of carbamylated albumin by extended hemodialysis.Mass Spectrometry-Based Proteomic Study Makes High-Density Lipoprotein a Biomarker for Atherosclerotic Vascular Disease.The urea decomposition product cyanate promotes endothelial dysfunction.Longitudinal Changes in Protein Carbamylation and Mortality Risk after Initiation of HemodialysisEosinophil Peroxidase Catalyzed Protein Carbamylation Participates in Asthma.Carbamylated Low-Density Lipoprotein and Thrombotic Risk in Chronic Kidney Disease.HEMO Revisited: Why Kt/Vurea Only Tells Part of the StoryCarbamylated low-density lipoprotein induces endothelial dysfunction.Biochemical and Clinical Impact of Organic Uremic Retention Solutes: A Comprehensive Update.Nutritional therapy reduces protein carbamylation through urea lowering in chronic kidney disease.Chronic Kidney Disease and Disproportionally Increased Cardiovascular Damage: Does Oxidative Stress Explain the Burden?Mechanisms and consequences of carbamoylation.Tolvaptan promotes urinary excretion of sodium and urea: a retrospective cohort study.Interaction of carbamylated LDL with LOX-1 in the induction of endothelial dysfunction and atherosclerosis.Chronic kidney disease alters lipid trafficking and inflammatory responses in macrophages: effects of liver X receptor agonism.Homocitrulline: a new marker for differentiating acute from chronic renal failure.The Role of Gut Microbiota and Diet on Uremic Retention Solutes Production in the Context of Chronic Kidney Disease.Myeloperoxidase derived oxidants damage artery wall proteins in an animal model of chronic kidney disease accelerated atherosclerosis.Increased carbamylation level of HDL in end-stage renal disease: carbamylated-HDL attenuated endothelial cell function.Human monoclonal Fab and human plasma antibodies to carbamyl-epitopes cross-react with malondialdehyde-adductsGut Microbiota and Cardiovascular Uremic Toxicities
P2860
Q26827410-50BBFD16-9827-4F90-BD5F-C28FEA792EEAQ28074264-473FC981-F37B-4CAE-9B02-726CD53D5A45Q28083619-F7DAFB69-CDB4-41EF-B260-6B2509AD4213Q33749281-B22A99CE-20C5-4107-BBB9-CCD5B50569A7Q34403945-B2FDEBCC-BE9F-4121-BEA4-FCD00E86BC1DQ34995574-22399BDC-87DA-47CD-9A85-88454C26C79BQ35064221-A50FE0B8-CC2A-49C3-B0E6-C8E9F0C5CEBFQ35080035-2648B399-2D5D-459D-A255-CE88BD5DB564Q35239148-2719FEC4-AA54-4929-9A6E-8911673EA49FQ35667666-2FC0D4C0-9606-416E-BF48-C3DC5CD7FA40Q35748662-C139F507-3394-4935-B7BE-0181FFE41474Q36223659-FA54449F-C123-4424-A3D4-D0D5BA1F12BBQ36563327-CF437B65-911A-4B1D-A515-71FA30F0F72DQ36994914-5BA9E2CA-3189-49DE-A3EA-B44AC1541AC7Q37217519-1583F9A1-C4F1-4F00-8D2F-0B41820FCFB9Q37280857-C4D4B08F-7ECA-43C3-BA66-4CA978CF1764Q38415749-FABC0CFA-8115-45AD-97B3-18A468FEBCFDQ38591546-FFCA1AD9-0843-4004-83C0-82F9883D5133Q41643100-55FF07D0-7105-424D-AA9D-F44FC4F57BC0Q41908048-896F5B30-D22B-485E-BB3E-8B77F0A4C208Q42025075-6B79D06A-6308-4159-8333-93A8FB184289Q42110772-677BC3D2-6926-4A60-914E-1D8A20FF53FDQ42383182-7B1F8792-6594-48F1-B34F-EFCA06494C83Q42616697-45BD4C5E-EA95-4BE3-90EC-353E3FD394E0Q42722929-909A11C1-B9BC-4E2A-A9D0-C9397FA8334AQ46915576-B7BFFFBF-5D33-47E5-ADA9-E4489F9E1552Q47216784-3961F3D4-164F-421C-9363-3AF4AFCEE082Q47676591-EBB59F2C-F277-417E-9F4B-A29E6E17A064Q47732797-A3D729F5-570A-465C-BFC3-3FE9DC9E2783Q48010750-AC99E697-6C47-4482-A63B-D431324CB69DQ48156467-EC7EB0E8-E8BB-44D9-9DE1-D634A6C8E327Q48320976-BD99ECD7-776D-4B6B-A879-242E1CADD3F6Q49645186-2F7CD2F2-B400-445A-A322-35640B4CA702Q50541406-AFB158D2-6D92-4B5A-8789-F9F40BAD6CF4Q52589945-6DDBD726-94BF-4C6A-ABF7-CAF1B1A2C552Q52629638-2FB7B475-3D03-42B5-9C17-ABBA21475D61Q54222366-A23E3D68-2FFC-4217-810A-D7D573012692Q56891373-32F675E7-CCB2-4FDD-92F1-0865A4B98495Q57176511-C8140857-FEC5-44BD-A777-56A12D7585A2
P2860
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Protein carbamylation predicts mortality in ESRD.
@en
type
label
Protein carbamylation predicts mortality in ESRD.
@en
prefLabel
Protein carbamylation predicts mortality in ESRD.
@en
P2093
P2860
P356
P1476
Protein carbamylation predicts mortality in ESRD.
@en
P2093
Robert A Koeth
Stanley L Hazen
W H Wilson Tang
Xiaoming Fu
P2860
P304
P356
10.1681/ASN.2012030254
P577
2013-02-21T00:00:00Z